Lessons from the HPTN 071 (PopART) trial

Lancet HIV. 2022 Nov;9(11):e736-e737. doi: 10.1016/S2352-3018(22)00304-6.
No abstract available

MeSH terms

  • Anti-HIV Agents* / therapeutic use
  • HIV Infections* / drug therapy
  • HIV Infections* / epidemiology
  • HIV Infections* / prevention & control
  • Humans
  • Mass Screening
  • Randomized Controlled Trials as Topic
  • South Africa / epidemiology
  • Zambia / epidemiology

Substances

  • Anti-HIV Agents